Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New trial

posted on May 25, 2021 10:36PM

That's just a Phase I study, ending in 2023. It suggests to me that we will likely have a very long wait until a payday.

3 Recommendations

May 26, 2021 09:35AM

May 26, 2021 01:25PM

May 26, 2021 02:56PM

fuzzyjr

May 27, 2021 04:13PM

May 28, 2021 10:57PM

May 28, 2021 11:12PM

May 29, 2021 10:08AM

fuzzyjr

May 29, 2021 10:12AM

Reply New Message

Back To Forum List View

Please to post a reply